{"title":"Factors affecting the number of retrieved lymph nodes and the impact on the prognosis in Stage II/III right-sided colon cancer.","authors":"Rika Ono, Tetsuro Tominaga, Yuma Takamura, Hiroki Katayama, Shintaro Hashimoto, Mariko Yamashita, Hiroshi Maruta, Keisuke Noda, Makoto Hisanaga, Kaido Oishi, Masaaki Moriyama, Fumitake Uchida, Toshio Shiraishi, Masaki Kunizaki, Takashi Nonaka, Keitaro Matsumoto","doi":"10.1007/s00595-026-03349-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The risk factors and prognostic implications of retrieving fewer than 12 lymph nodes in patients undergoing laparoscopic/robot-assisted right colectomy remain unclear.</p><p><strong>Methods: </strong>A total of 993 patients with Stage II/III right-sided colon cancer who underwent minimally invasive surgery between 2016 and 2024 were reviewed. Patients were divided into two groups: those with < 12 retrieved lymph nodes (low lymph node [L-LN] group, n = 139) and those with ≥ 12 retrieved lymph nodes (high lymph node [H-LN] group, n = 854). The clinicopathological characteristics and prognosis were compared between the groups.</p><p><strong>Results: </strong>A multivariate analysis revealed that BMI > 25 kg/m<sup>2</sup> (odds ratio [OR] 1.508; 95% confidence interval [CI] 1.004-2.266; p = 0.047), no colonic stent insertion (OR 3.500; 95%CI 1.077-11.378: p = 0.037), and a clinical node-negative status (OR 1.535 95%CI 1.050-2.242: p = 0.026) were independent predictors of retrieval of < 12 lymph nodes. In both Stage II (100% vs. 79.5%, p < 0.05) and Stage III (100% vs. 63.6%, p = 0.07) patients, adjuvant chemotherapy resulted in better outcomes than no adjuvant chemotherapy.</p><p><strong>Conclusion: </strong>In minimally invasive right colectomy, a high BMI and clinically node-negative disease were associated with a reduced number of dissected lymph nodes. As potentially inadequate dissection may contribute to a poor prognosis, adjuvant therapy should be considered in selected patients.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"2211-2217"},"PeriodicalIF":2.3000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery Today","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00595-026-03349-2","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/4 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: The risk factors and prognostic implications of retrieving fewer than 12 lymph nodes in patients undergoing laparoscopic/robot-assisted right colectomy remain unclear.
Methods: A total of 993 patients with Stage II/III right-sided colon cancer who underwent minimally invasive surgery between 2016 and 2024 were reviewed. Patients were divided into two groups: those with < 12 retrieved lymph nodes (low lymph node [L-LN] group, n = 139) and those with ≥ 12 retrieved lymph nodes (high lymph node [H-LN] group, n = 854). The clinicopathological characteristics and prognosis were compared between the groups.
Results: A multivariate analysis revealed that BMI > 25 kg/m2 (odds ratio [OR] 1.508; 95% confidence interval [CI] 1.004-2.266; p = 0.047), no colonic stent insertion (OR 3.500; 95%CI 1.077-11.378: p = 0.037), and a clinical node-negative status (OR 1.535 95%CI 1.050-2.242: p = 0.026) were independent predictors of retrieval of < 12 lymph nodes. In both Stage II (100% vs. 79.5%, p < 0.05) and Stage III (100% vs. 63.6%, p = 0.07) patients, adjuvant chemotherapy resulted in better outcomes than no adjuvant chemotherapy.
Conclusion: In minimally invasive right colectomy, a high BMI and clinically node-negative disease were associated with a reduced number of dissected lymph nodes. As potentially inadequate dissection may contribute to a poor prognosis, adjuvant therapy should be considered in selected patients.
期刊介绍:
Surgery Today is the official journal of the Japan Surgical Society. The main purpose of the journal is to provide a place for the publication of high-quality papers documenting recent advances and new developments in all fields of surgery, both clinical and experimental. The journal welcomes original papers, review articles, and short communications, as well as short technical reports("How to do it").
The "How to do it" section will includes short articles on methods or techniques recommended for practical surgery. Papers submitted to the journal are reviewed by an international editorial board. Field of interest: All fields of surgery.